Phio Pharmaceuticals Corp. (PHIO)
Phio Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
Owlet Inc. (OWLT)
Owlet Reports Third Quarter 2025 Financial Results
Nanobiotix S.A. (NBTX)
NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations
Ainos Inc. (AIMD)
Ainos Reports Third Quarter 2025 Financial Results
Calidi Biotherapeutics Inc (CLDI)
Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights
Elicio Therapeutics Inc (ELTX)
A New Press Release from Elicio Therapeutics
Omeros Corporation (OMER)
Omeros Corporation Reports Third Quarter 2025 Financial Results
Acrivon Therapeutics Inc (ACRV)
Acrivon Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
ORIC Pharmaceuticals Inc (ORIC)
ORIC® Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Clinical and Operational Updates
VolitionRX Limited (VNRX)
VolitionRx Limited Announces Third Quarter 2025 Financial Results and Business Update